SARS-CoV-2-IN-61

• UNSPSC Description:

  SARS-CoV-2-IN-61 (compound 8i) is a SARS CoV-2 PLpro inhibitor with an IC50 of 16 µM. SARS-CoV-2-IN-61 has antiviral activities[1].

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/sars-cov-2-in-61.html

• Solubility:

  10 mM in DMSO

• Smiles:

  C[C@@H](NC(C1=CC(C(N(CCC)CCC)=O)=CC=C1)=O)C2=CC=CC3=CC=CC=C32

• Molecular Weight:

  402.53

• References & Citations:

  [1]Arun K Ghosh, et al. SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads. Bioorg Med Chem Lett. 2023 Sep 27:96:129489.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  3044004-40-9